Coming soon - Get a detailed view of why an account is flagged as spam!
view details

This post has been de-listed

It is no longer included in search results and normal feeds (front page, hot posts, subreddit posts, etc). It remains visible only via the author's post history.

27
Data readouts potentially in April and June
Post Flair (click to view more posts with a particular flair)
Post Body

https://www.pharmaceutical-technology.com/news/atossa-therapeutics-progresses-phase-ii-preventative-breast-cancer-therapy/

Dr quay mentions in this article about potential readouts in April and June , also talks about discussions with the FDA about phase 3 trials

Also discusses about a possible partnership moving forward after phase 2? How does that work in ter.s of value to share holders ? Is it a more profitable long term plan or is a buyout more preferable?

Comments

Buyout is preferable. Quay himself has said he wants to sell to big pharma eventually. ATOS would need to raise more money to carry this drug to market, plus we don’t have a sales/marketing team, etc.

Big pharma typically buys promising drugs after a good phase 2 so they can run phase 3 themselves.

Author
Account Strength
10%
Account Age
9 months
Verified Email
No
Verified Flair
No
Total Karma
444
Link Karma
151
Comment Karma
293
Profile updated: 4 days ago

Subreddit

Post Details

We try to extract some basic information from the post title. This is not always successful or accurate, please use your best judgement and compare these values to the post title and body for confirmation.
Posted
9 months ago